Evidence map›Paper›PMID 34787568›Full record

ArticleeLife2021

mTOR-dependent translation drives tumor infiltrating CD8

Benedetta De Ponte Conti, Annarita Miluzio, Fabio Grassi, Sergio Abrignani, Stefano Biffo, Sara Ricciardi

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Benedetta De Ponte ContiInstitute for Research in Biomedicine, Università della Svizzera Italiana (USI), Bellinzona, Switzerland.
Annarita MiluzioIstituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
Fabio GrassiInstitute for Research in Biomedicine, Università della Svizzera Italiana (USI), Bellinzona, Switzerland.
Sergio AbrignaniIstituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
Stefano BiffoIstituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.ORCID https://orcid.org/0000-0002-3780-1050
Sara RicciardiIstituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.ORCID https://orcid.org/0000-0001-8124-432X
University of Milan · ITIstituto Nazionale Genetica Molecolare · ITUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We performed a systematic analysis of the translation rate of tumor-infiltrating lymphocytes (TILs) and the microenvironment inputs affecting it, both in humans and in mice. Measurement of puromycin incorporation, a proxy of protein synthesis, revealed an increase of translating CD4

Indexed as

CD4-Positive T-LymphocytesCD8-Positive T-LymphocytesLymphocytes, Tumor-InfiltratingTOR Serine-Threonine KinasesMTOR protein, humanmTOR protein, mouseTOR Serine-Threonine KinasesCD4+CD8+cell biologyhumanimmunologyinflammationmousetranslationTreg

Identifiers

PMID34787568
PMCPMC8598161
OpenAlexW3212074544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.